Genes essential for early events in gonadal development

Cellular and Molecular Life Sciences

Volumn 55, Issue 6-7, 1999, Pages 831-838

  Parker, K L ^a   Schimmer, B P ^b   Schedl, A ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

DAX 1; MIS; Sex determination; SF 1; WT1

Indexed keywords

STEROIDOGENIC FACTOR 1; TRANSCRIPTION FACTOR;

ARTICLE; FERTILIZATION; GENE MUTATION; GONAD DEVELOPMENT; MAMMAL; MOLECULAR GENETICS; NONHUMAN; OVARY; PHENOTYPE; SEX DIFFERENTIATION; SEXUAL DEVELOPMENT; TESTIS; Y CHROMOSOME;

EID: 0033048212     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050337     Document Type: Article

References (55)

1. 1 Jost A. (1953) Studies on sex differentiation in mammals. Recent Prog. Horm. Res. 8: 379-418
2. 2 Jost A., Vigier B., Prepin J. and Perchellet J. (1973) Studies on sex differentiation in mammals. Recent Prog. Horm. Res. 29: 1-41
3. 3 Wilson J. D., Griffin J. E. and Russell D. W. (1993) Steroid 5 alpha-reductase 2 deficiency. Endocr. Rev. 14: 577-593
4. 4 Russell D. W., Goodfellow P. N. and Lovell-Badge R. (1993) SRY and sex determination in mammals. Annu. Rev. Genet. 27: 71-92
5. 5 Hastie N. D. (1993) The genetics of Wilms' tumor - a case of disrupted development. Annu. Rev. Genet. 28: 523-558
6. 6 Miller R. W., Fraumeni J. F. and Manning M. D. (1964) Association of Wilms' tumor with aniridia, hemihypertrophy and other congenital anomalies. N. Engl. J. Med. 270: 922-927
7. 7 Call K., Glaser T., Ito C., Buckler A. J., Pelletier J., Haber D. A. et al. (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60: 509-520
8. 8 Gessler M., Poustka A., Cavenee W., Neve R. L., Orkin S. H. and Bruns G. A. (1990) Homozygous deletion in Wilms' tumours of a gene identified by chromosome jumping. Nature 343: 774-778
9. 9 Haber D. A., Buckler A. J., Glaser T., Call K. M., Pelletier J., Sohn R. L. et al. (1990) An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell 61: 1257-1269
10. 10 Ton C. C., Hirvonen H., Miwa H., Weil M. M., Monaghan P., Jordan T. et al. (1991) Positional cloning and characterisation of a paired box-and horneobox-containing gene from the aniridia region. Cell 67: 1059-1074
11. 11 Schwartz F., Eisenman R., Knoll J., Gessler M. and Bruns G. (1995) cDNA sequence, genomic organization and evolutionary conservation of a novel gene from the WAGK region. Genomics 29: 526-532
12. 12 Kent J., Lee M., Schedl A., Boyle S., Fantes J., Powell M. et al. (1997) The reticulocalbindin gene maps to the WAGR region in man and to the Small eye Harwell deletion in mouse. Genomics 42: 260-267
13. 13 Haber D. A., Sohn R. L., Buckler A. J., Pelletier J., Call K. M. and Housman D. E. (1991) Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc. Natl. Acad. Sci. USA 88: 9618-9622
14. 14 Bruening W. and Pelletier J. (1996) A non-AUG translation initiation event generates novel WT1 isoforms. J. Biol. Chem. 271: 8646-8654
15. 15 Bickmore W. A., Oghene K., Little M. H., Seawright A., van Heyningen V. and Hastie N. D. (1992) Modulation of DNA binding specificity by alternative splicing of the Wilms' tumour wt1 gene transcript. Science 257: 235-237
16. 16 Larsson S. H., Charlieu J. P., Miyagawa K., Engelkamp D., Rassoulzadegan M., Ross A, et al. (1995) Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81: 391-401
17. 17 Englert C., Vidal M., Maheswaran S., Ge Y., Ezzell R., Isselbacher K. J. et al. (1995) Truncated WT1 mutants alter the subnuclear localization of the wild-type protein. Proc. Natl. Acad. Sci. USA 92: 11960-11964
18. 18 Pritchard-Jones K., Fleming S., Davidson D., Bickmore W., Porteous D., Gosden C. et al. (1990) The candidate Wilms' tumor gene is involved in genitourinary development. Nature 346: 194-197
19. 19 Pelletier J., Bruening W., Li F. P., Haber D. A., Glaser T. and Housman D. E. (1991) WT1 mutations contribute to abnormal genital ystem development and hereditary Wilms' tumor. Nature 353: 431-434
20. 20 Kreidberg J. A., Sariola H., Loring J. M., Maeda M., Pelletier J., Housman D. et al. (1993) WT-1 is required for early kidney development. Cell 74: 679-691
21. 21 Pelletier J., Bruening W., Kashtan C. E., Mauer S. M., Manivel J. C., Striegel J. E. et al. (1991) Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67: 437-447
22. 22 Bruening W., Bardeesy N., Silverman B. L., Cohn R. A., Machin G. A., Aronson A. J. et al. (1992) Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development. Nature Genet. 1: 144-148
23. 23 Hastie N. D. (1993) Dominant negative mutations in the Wilms' tumour (WT1) gene cause Denys-Drash syndrome-proof that a tumour-suppressor gene plays a crucial role in normal genitourinary development. Hum. Mol. Genet. 1: 293-295
24. 24 Moffet P., Bruening W., Nakgama H., Bardeesy N., Housman D., Housman D. E. et al. (1995) Antagonism of WT1 activity by protein self-association. Proc. Natl. Acad. Sci. USA 92: 11105-11109
25. 25 Reddy J. C., Morris J. C., Wang J., English M. A., Haber D. A., Shi Y. et al. (1995) WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins. J. Biol. Chem. 270: 10878-10884
26. 26 Barbaux S., Niaudet P., Gubler M. C., Grunfeld J. P., Jaubert F., Kuttenn F. et al. (1997) Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nature Genet. 17: 467-470
27. 27 Klamt B., Koziell A., Poulat F., Wicacker P., Scambler P., Berta P. et al. (1998) Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms. Hum. Mol. Genet. 7: 709-714
28. 28 Kikuchi H., Takata A., Akasaka Y., Fukuzawa R., Yoneyama H., Kurosawa Y. et al. (1998) Do intronic mutations affecting splicing of WT1 exon 9 cause Frasier syndrome? J. Med. Genet. 35: 45-48
29. 29 Lala D. S., Rice D. A. and Parker K. L. (1992) Steroidogenic factor 1, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor 1. Mol. Endocrinol. 6: 1249-1258
30. 30 Honda S.-I., Morohashi K.-I., Nomura M., Takeya H., Kitajima M. and Omura T. (1993) Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. J. Biol. Chem. 268: 7494-7502
31. 31 Evans R. M. (1998) The steroid and thyroid hormone receptor superfamily. Science 240: 889-895
32. 32 Parker K. L. and Schimmer B. P. (1997) Steroidogenic factor I: a key determinant of endocrine development and function. Endocrine Rev. 18: 361-377
33. 33 Shen W. H., Moore C. C. D., Ikeda Y., Parker K. L. and Ingraham H. A. (1994) Nuclear receptor steroidogenic factor 1 regulates MIS gene expression: a link to the sex determination cascade. Cell 77: 651-661
34. 34 Hatano O., Takayama K., Imai T., Waterman M. R., Takakusu A., Omura T. et al. (1995) Sex-dependent expression of a transcription factor, Ad4BP, regulating steroidogenic P-450 genes in the gonads during prenatal and postnatal rat development. Development 120: 2787-2797
35. 35 Giuili G., Shen W. H. and Ingraham H. A. (1997) The nuclear receptor SF-1 mediates sexually dimorphic expression of Mullerian inhibiting substance, in vivo. Development 124: 1799-1807
36. 36 Luo X., Ikeda Y. and Parker K. L. (1994) A cell-specific nuclear receptor is essential for adrenal and gonadal development and for male sexual differentiation. Cell 77: 481-490
37. 37 Sadovsky Y., Crawford P. A., Woodson K. G., Polish J. A., Clements M. A., Tourtellotte L. M. et al. (1995) Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. Proc. Natl. Acad. Sci. USA 92: 10939-10943
38. 38 Ingraham H. A., Lala D. S., Ikeda Y., Luo X., Shen W. H., Nachtigal M. W. et al. (1994) The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev. 8: 2302-2312
39. 39 Shinoda K., Lei H., Yoshii H., Nomura M., Nagano M., Shiba H. et al. (1995) Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz-F1-disrupted mice. Dev. Dyn. 204: 22-29
40. 40 Ikeda Y., Luo X., Abbud R., Nilson J. H. and Parker K. L. (1995) The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. Mol. Endocrinol. 9: 478-486
41. 41 Canteras N. S., Simerly R. B. and Swanson L. W. (1994) Organization of projections from the ventromedial hypothalamic nucleus of the hypothalamus: a Phaseolus vulgaris-leucoagglutinin study in the rat. J. Comp. Neurol. 348: 41-79
42. 42 Oba K., Yanase T., Nomura M., Morohashi K., Takayanagi R. and Nawata H. (1996) Structural characterization of human Ad4BP (SF-1) gene. Biochem. Biophys. Res. Commun. 226: 261-267
43. 43 Wong M., Ramayya M. S., Chrousos G. P., Driggers P. H. and Parker K. L. (1996) Cloning and sequence analysis of the human gene encoding steroidogenic factor 1. J. Mol. Endocrinol. 17: 139-147
44. 44 Ramayya M. S., Zhou J., Kino T., Segars J. H., Bondy C. A. and Chrousos G. P. (1997) Steroidogenic factor 1 messenger ribonucleic acid expression in steroidogenic and nonsteroidogenic human tissues: Northern blot and in situ hybridization studies. J. Clin. Endocrinol. Metab. 82: 1799-1806
45. 45 Taketo M., Parker K. L., Howard T. A., Tsukiyama T., Wong M., Niwa O. et al. (1995) Homologs of Drosophila fushi tarazu factor 1 map to mouse chromosome 2 and human chromosome 9q33. Genomics 25: 565-567
46. 46 Nachtigal M. W., Hirokawa Y., Enjeart-VanHouten D. L., Flanagan J. N., Hammer G. D. and Ingraham H. A. (1998) Wilms' tumor I and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell 93: 445-454
47. 47 De Santa Barbara P., Bonneaud N., Boizet B., Desclozeaux M., Moniot B., Sudbeck P. et al. (1998) Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Müllerian hormone gene. Mol. Cell. Biol. 18: 6653-6665
48. 48 Zanaria E., Muscatelli F., Bardoni B., Strom T. M., Guioli S., Guo W. et al. (1994) An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372: 635-641
49. 49 Swain A., Zanaria E., Hacker A., Lovell-Badge R. and Camerino G. (1996) Mouse Dax-1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function. Nature Genet. 12: 404-409
50. 50 Ikeda Y., Swain A., Weber T. J., Hentges K. E., Zanaria E., Lalli E. et al. (1996) Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: potential links in endocrine development. Mol. Endocrinol. 10: 1261-1272
51. 51 Ito M., Yu R. and Jameson J. L. (1997) DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol. Cell Biol. 17: 1476-1483
52. 52 Crawford P. A., Dorn C., Sadovsky Y. and Milbrandt J. (1998) Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1. Mol. Cell. Biol. 18: 2949-5629
53. 53 Zazopoulos E., Lalli E., Stocco D. M. and Sassone-Corsi P. (1997) DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature 390: 311-315
54. 54 Burris T. P., Guo W., Le T. and McCabe E. R. (1995) Identification of a putative steroidogenic factor-1 response element in the DAX-1 promoter. Biochem. Biophys. Res. Commun. 214: 576-581
55. 55 Yu R. N., Ito M. and Jameson J. L. (1998) The murine Dax-1 promoter is stimulated by SF-1 (steroidogenic factor-1) and inhibited by COUP-TF (chicken ovalbumin upstream promoter-transcription factor) via a composite nuclear receptor regulatory element. Mol. Endocrinol. 12: 1010-1022